Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Stryker ( (SYK) ) has shared an update.
On January 28, 2025, Stryker announced the retirement of Glenn S. Boehnlein from his role as Vice President, Chief Financial Officer, effective April 1, 2025. Preston Wells, currently Vice President, Group Chief Financial Officer for Orthopaedics, will be promoted to Vice President, Chief Financial Officer on the same date. This leadership transition is expected to support Stryker’s ongoing growth, with Wells’s extensive experience in financial management and strategic leadership set to enhance the company’s operations and market position.
More about Stryker
Stryker is a global leader in medical technologies, offering innovative products and services in MedSurg, Neurotechnology, and Orthopaedics to improve patient and healthcare outcomes. The company impacts more than 150 million patients annually alongside its customers worldwide.
YTD Price Performance: 11.48%
Average Trading Volume: 1,360,601
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $150.3B
For detailed information about SYK stock, go to TipRanks’ Stock Analysis page.
